Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABP-745 in Acute Gout Flare
NCT07145229Phase 2Completed
- Sponsor
- Atom Therapeutics
- Start
- Aug 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ABP-745 in acute gouty arthritis, sponsored by Atom Therapeutics. Started Aug 2025; status: completed.
02
Drugs
ABP-745
03
Conditions
acute gouty arthritis
Beyond the preview
Go deeper on NCT07145229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07145229.